{"id":"https://openalex.org/W2000820465","doi":"https://doi.org/10.1038/sj.bjc.6603969","title":"Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel","display_name":"Sequence dependent antitumour efficacy of the vascular disrupting agent ZD6126 in combination with paclitaxel","publication_year":2007,"publication_date":"2007-09-11","ids":{"openalex":"https://openalex.org/W2000820465","doi":"https://doi.org/10.1038/sj.bjc.6603969","mag":"2000820465","pmid":"https://pubmed.ncbi.nlm.nih.gov/17848949","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2360417"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjc.6603969","doi":"https://doi.org/10.1038/sj.bjc.6603969","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6603969","pdf_url":"https://www.nature.com/articles/6603969.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/6603969.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"M Martinelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M Martinelli","raw_affiliation_strings":["Laboratory of Biology and Treatment of Metastasis, Department of Oncology, Mario Negri Institute for Pharmacological Research, Bergamo 24125, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Biology and Treatment of Metastasis, Department of Oncology, Mario Negri Institute for Pharmacological Research, Bergamo 24125, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051380079","display_name":"Katiuscia Bonezzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"K Bonezzi","raw_affiliation_strings":["Department of Oncology, Laboratory of Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, 24125, Italy","Department of Oncology, Laboratory of Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Laboratory of Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, 24125, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of Oncology, Laboratory of Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070893182","display_name":"Elena Riccardi","orcid":"https://orcid.org/0000-0002-3873-390X","observed_orcids":["https://orcid.org/0000-0002-3873-390X"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"E Riccardi","raw_affiliation_strings":["Department of Oncology, Laboratory of Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, 24125, Italy","Department of Oncology, Laboratory of Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Laboratory of Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, 24125, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of Oncology, Laboratory of Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028627843","display_name":"Elisabetta Kuhn","orcid":"https://orcid.org/0000-0003-0620-3821","observed_orcids":["https://orcid.org/0000-0003-0620-3821"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"E Kuhn","raw_affiliation_strings":["Department of Oncology, Laboratory of Cancer Pharmacology, Mario Negri Institute for Pharmacological Research, Milano, 20156, Italy","Department of Oncology, Laboratory of Cancer Pharmacology, Mario Negri Institute for Pharmacological Research, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Laboratory of Cancer Pharmacology, Mario Negri Institute for Pharmacological Research, Milano, 20156, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of Oncology, Laboratory of Cancer Pharmacology, Mario Negri Institute for Pharmacological Research, Milano, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079394240","display_name":"Roberta Frapolli","orcid":"https://orcid.org/0000-0003-2907-273X","observed_orcids":["https://orcid.org/0000-0003-2907-273X"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"R Frapolli","raw_affiliation_strings":["Department of Oncology, Laboratory of Cancer Pharmacology, Mario Negri Institute for Pharmacological Research, Milano, 20156, Italy","Department of Oncology, Laboratory of Cancer Pharmacology, Mario Negri Institute for Pharmacological Research, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Laboratory of Cancer Pharmacology, Mario Negri Institute for Pharmacological Research, Milano, 20156, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of Oncology, Laboratory of Cancer Pharmacology, Mario Negri Institute for Pharmacological Research, Milano, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056006346","display_name":"Massimo Zucchetti","orcid":"https://orcid.org/0000-0002-5427-052X","observed_orcids":["https://orcid.org/0000-0002-5427-052X"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M Zucchetti","raw_affiliation_strings":["Department of Oncology, Laboratory of Cancer Pharmacology, Mario Negri Institute for Pharmacological Research, Milano, 20156, Italy","Department of Oncology, Laboratory of Cancer Pharmacology, Mario Negri Institute for Pharmacological Research, Milano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Laboratory of Cancer Pharmacology, Mario Negri Institute for Pharmacological Research, Milano, 20156, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of Oncology, Laboratory of Cancer Pharmacology, Mario Negri Institute for Pharmacological Research, Milano, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107537939","display_name":"Anderson Joseph Ryan","orcid":"https://orcid.org/0000-0001-6241-7969","observed_orcids":["https://orcid.org/0000-0001-6241-7969"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A J Ryan","raw_affiliation_strings":["AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, UK","Astrazeneca, Alderley Park, Macclesfield, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Alderley Park, Macclesfield, SK10 4TG, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Astrazeneca, Alderley Park, Macclesfield, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018599202","display_name":"Giulia Taraboletti","orcid":"https://orcid.org/0000-0001-8780-5001","observed_orcids":["https://orcid.org/0000-0001-8780-5001"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"G Taraboletti","raw_affiliation_strings":["Department of Oncology, Laboratory of Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, 24125, Italy","Department of Oncology, Laboratory of Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Laboratory of Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, 24125, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of Oncology, Laboratory of Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000996905","display_name":"Raffaella Giavazzi","orcid":"https://orcid.org/0000-0001-5249-8208","observed_orcids":["https://orcid.org/0000-0001-5249-8208"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"R Giavazzi","raw_affiliation_strings":["Department of Oncology, Laboratory of Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, 24125, Italy","Department of Oncology, Laboratory of Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Laboratory of Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, 24125, Italy","institution_ids":["https://openalex.org/I19630809"]},{"raw_affiliation_string":"Department of Oncology, Laboratory of Biology and Treatment of Metastasis, Mario Negri Institute for Pharmacological Research, Bergamo, Italy","institution_ids":["https://openalex.org/I19630809"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5018599202"],"corresponding_institution_ids":["https://openalex.org/I19630809"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":2.0673,"has_fulltext":true,"cited_by_count":53,"citation_normalized_percentile":{"value":0.86563179,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"97","issue":"7","first_page":"888","last_page":"894"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.007699999958276749,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zd6126","display_name":"ZD6126","score":0.9860000014305115},{"id":"https://openalex.org/keywords/vascular-disrupting-agents","display_name":"vascular disrupting agents","score":0.8069999814033508},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9959999918937683},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8450000286102295},{"id":"https://openalex.org/keywords/medication-scheduling","display_name":"drug scheduling","score":0.6050000190734863},{"id":"https://openalex.org/keywords/drug-sequence","display_name":"drug sequence","score":0.628000020980835},{"id":"https://openalex.org/keywords/tumor-necrosis","display_name":"tumor necrosis","score":0.753000020980835},{"id":"https://openalex.org/keywords/tumor-cell-proliferation","display_name":"tumor cell proliferation","score":0.8130000233650208},{"id":"https://openalex.org/keywords/antitumour-efficacy","display_name":"antitumour efficacy","score":0.796999990940094}],"concepts":[{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.804161787033081},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6895614862442017},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.5462852716445923},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5462531447410583},{"id":"https://openalex.org/C503630168","wikidata":"https://www.wikidata.org/wiki/Q178069","display_name":"Necrosis","level":2,"score":0.4858998656272888},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4271068871021271},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4242950677871704},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34696513414382935},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2903481125831604}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008938","descriptor_name":"Mitosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009336","descriptor_name":"Necrosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009943","descriptor_name":"Organophosphorus Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1038/sj.bjc.6603969","doi":"https://doi.org/10.1038/sj.bjc.6603969","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6603969","pdf_url":"https://www.nature.com/articles/6603969.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmid:17848949","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17848949","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2360417","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2360417/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmh:oai:air.unimi.it:2434/785050","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2434/785050","pdf_url":null,"source":{"id":"https://openalex.org/S4306400516","display_name":"Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I189158943","host_organization_name":"University of Milan","host_organization_lineage":["https://openalex.org/I189158943"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1038/sj.bjc.6603969","doi":"https://doi.org/10.1038/sj.bjc.6603969","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjc.6603969","pdf_url":"https://www.nature.com/articles/6603969.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320321781","display_name":"Ministero della Salute","ror":"https://ror.org/00789fa95"},{"id":"https://openalex.org/F4320323054","display_name":"Associazione Italiana per la Ricerca sul Cancro","ror":"https://ror.org/02g2x7380"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2000820465.pdf","grobid_xml":"https://content.openalex.org/works/W2000820465.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W1563453192","https://openalex.org/W1966726954","https://openalex.org/W1989505743","https://openalex.org/W1992375630","https://openalex.org/W2007989814","https://openalex.org/W2021951737","https://openalex.org/W2023115975","https://openalex.org/W2036564049","https://openalex.org/W2046714964","https://openalex.org/W2084261621","https://openalex.org/W2084740377","https://openalex.org/W2085802928","https://openalex.org/W2090852550","https://openalex.org/W2094183844","https://openalex.org/W2096704471","https://openalex.org/W2097879177","https://openalex.org/W2098282622","https://openalex.org/W2100945863","https://openalex.org/W2108782485","https://openalex.org/W2112977795","https://openalex.org/W2114313021","https://openalex.org/W2114592067","https://openalex.org/W2114766467","https://openalex.org/W2134660444","https://openalex.org/W2136783006","https://openalex.org/W2142760959","https://openalex.org/W2146353624","https://openalex.org/W2152574565","https://openalex.org/W2154358347","https://openalex.org/W2166186123","https://openalex.org/W2167833770","https://openalex.org/W2414615250","https://openalex.org/W2416794060"],"related_works":["https://openalex.org/W1989505743","https://openalex.org/W2041643878","https://openalex.org/W2135900203","https://openalex.org/W2112977795","https://openalex.org/W104605948","https://openalex.org/W2046490449","https://openalex.org/W2426674950","https://openalex.org/W2000374713","https://openalex.org/W2003420178","https://openalex.org/W2053380829"],"abstract_inverted_index":{"The":[0],"clinical":[1],"success":[2],"of":[3,25,35,53,60,71,113,124,194,220,227],"small-molecule":[4],"vascular":[5,117],"disrupting":[6],"agents":[7],"(VDAs)":[8],"depends":[9],"on":[10,57],"their":[11],"combination":[12,27,42,223],"with":[13,43,149,188,224],"conventional":[14],"therapies.":[15],"Scheduling":[16],"and":[17,50,55,87,119,136,211,230,247],"sequencing":[18],"remain":[19],"key":[20],"issues":[21],"in":[22,41,164,167,215,222,233],"the":[23,32,51,58,61,144,168,179,217,234],"design":[24],"VDA-chemotherapy":[26],"treatments.":[28],"This":[29],"study":[30],"examined":[31],"antitumour":[33,146,218],"activity":[34,129],"ZD6126,":[36],"a":[37,46,104,110,122,161,200],"microtubule":[38],"destabilising":[39],"VDA,":[40],"paclitaxel":[44],"(PTX),":[45],"microtubule-stabilising":[47],"cytotoxic":[48],"drug,":[49],"influence":[52],"schedule":[54],"sequence":[56,210],"efficacy":[59,219],"combination.":[62],"Nude":[63],"mice":[64],"bearing":[65],"MDA-MB-435":[66],"xenografts":[67],"received":[68],"weekly":[69,192],"cycles":[70],"ZD6126":[72,92,137,150,177,189],"(200":[73],"mg":[74,89],"kg(-1)":[75,90],"i.p.)":[76],"administered":[77],"at":[78],"different":[79],"times":[80],"before":[81,152],"or":[82,95],"after":[83,98,141,176],"PTX":[84,99,114,142,153,195,221],"(10,":[85],"20,":[86],"40":[88],"i.v.).":[91],"given":[93,138,151,173],"2":[94],"24":[96],"h":[97,140,175],"showed":[100],"no":[101],"significant":[102],"benefit,":[103],"result":[105],"that":[106,208],"was":[107,130,158,196],"attributed":[108],"to":[109,198,244],"protective":[111],"effect":[112],"against":[115],"ZD6126-induced":[116],"damage":[118],"tumour":[120,170,228,237],"necrosis,":[121],"hallmark":[123],"VDA":[125],"activity.":[126,147],"Paclitaxel":[127,172],"counteracting":[128],"reduced":[131],"by":[132,160,191],"distancing":[133],"drug":[134],"administrations,":[135],"72":[139,174],"potentiated":[143],"VDA's":[145],"Schedules":[148],"improved":[154],"therapeutic":[155,249],"activity,":[156],"which":[157],"paralleled":[159],"VDA-induced":[162],"increase":[163],"cell":[165],"proliferation":[166,232],"viable":[169,236],"tissue.":[171],"yielded":[178],"best":[180],"response":[181,202],"(50%":[182],"tumours":[183],"regressing).":[184],"A":[185],"single":[186],"treatment":[187],"followed":[190],"administration":[193],"sufficient":[197],"achieve":[199],"similar":[201],"(57%":[203],"remissions).":[204],"These":[205],"findings":[206],"show":[207],"schedule,":[209],"timing":[212],"are":[213],"crucial":[214],"determining":[216],"ZD6126.":[225],"Induction":[226],"necrosis":[229],"increased":[231],"remaining":[235],"tissue":[238],"could":[239],"be":[240],"exploited":[241],"as":[242],"readouts":[243],"optimise":[245],"schedules":[246],"maximise":[248],"efficacy.":[250]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}